24 HR mesalamine 375 MG Extended Release Oral Capsule [Apriso]

RxNorm concept 825134, branded drug (sbd). Prescribable name: Apriso 0.375 GM 24HR Extended Release Oral Capsule.

RxCUI: 825134
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/825134 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

mesalamine 52582

Other names

Apriso 375 MG 24 HR Extended Release Oral Capsule

Related concepts

mesalamine 375 MG (SCDC, consists of)
mesalamine 375 MG [Apriso] (SBDC, consists of)
Extended Release Oral Capsule (DF, has dose form)
Apriso (BN, has ingredient)
24 HR mesalamine 375 MG Extended Release Oral Capsule (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 825134 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/825134 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 825134. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.